Amphetamine/Dextroamphetamine XR Shortage Update: What Patients Need to Know in 2026

The Amphetamine/Dextroamphetamine XR Shortage: Where Do Things Stand in 2026?

If you rely on Amphetamine/Dextroamphetamine XR to manage your ADHD, the past few years have been exhausting. The shortage that began in October 2022 has dragged on far longer than anyone expected, disrupting treatment for millions of patients across the country.

In this update, we'll cover the current state of the shortage, why it's happening, what it's costing you, and — most importantly — what you can do about it right now.

Is Amphetamine/Dextroamphetamine XR Still in Shortage?

Yes, but the situation is improving. As of early 2026, the American Society of Health-System Pharmacists (ASHP) still lists amphetamine extended-release oral presentations as being in shortage. Several manufacturers have specific strengths on back order:

• 15 mg, 25 mg, and 30 mg extended-release capsules are the most affected, with some manufacturers estimating availability by late February 2026
• 5 mg, 10 mg, and 20 mg capsules have better availability but are still intermittently short at some pharmacies
• Multiple generic manufacturers (Teva, Sandoz, Lannett, and others) are producing the drug, but not all strengths are consistently available from every supplier

The FDA continues to monitor the situation and work with manufacturers to increase supply.

Why Has This Shortage Lasted So Long?

The shortage stems from a combination of factors that have proven difficult to resolve quickly:

DEA Production Quotas

As a Schedule II controlled substance, the total amount of amphetamine that can be manufactured each year is capped by the DEA. In October 2025, the DEA raised the aggregate production quota for d-amphetamine by roughly 25% — from 21.2 million grams to 26.5 million grams. This was the first significant increase, but it takes months for manufacturers to convert raw materials into finished products on pharmacy shelves.

Manufacturing Disruptions

Teva Pharmaceuticals, which produces more generic Adderall XR than any other manufacturer, experienced production delays starting in late 2022. Other manufacturers have faced their own challenges with raw material sourcing and quality assurance. The FDA has been working with companies to address these issues, but pharmaceutical manufacturing is not something that can be scaled up overnight.

Surging Demand

ADHD diagnoses in the United States have increased substantially, especially among adults. The expansion of telehealth during and after the pandemic made it easier for patients to get evaluated and treated. This increase in prescriptions — while representing better access to care — put additional pressure on an already strained supply.

What Does Amphetamine/Dextroamphetamine XR Cost in 2026?

Cost varies significantly depending on whether you have insurance and which pharmacy you use:

• Brand Adderall XR: $250-$450/month without insurance (30 capsules)
• Generic (retail, no discount): $200-$350/month
• Generic with discount coupon: $28-$80/month (SingleCare, GoodRx, and similar programs)
• With insurance: Typically $10-$50 copay for generic; brand may require prior authorization

The shortage has contributed to price variation between pharmacies. Some pharmacies charge more when supply is tight, which makes discount coupons even more valuable. For detailed savings strategies, read our guide on how to save money on Amphetamine/Dextroamphetamine XR.

Are There New Options Available?

While no brand-new amphetamine products have launched specifically to address this shortage, there are a few developments worth knowing about:

• Additional generic manufacturers have entered the market or expanded production of amphetamine mixed salts XR, which should improve availability over time
• Xelstrym (dextroamphetamine transdermal patch) offers an alternative delivery method for patients who can't find oral formulations
• Generic Vyvanse (Lisdexamfetamine) became available in 2023 and offers another long-acting option that may be easier to find

Talk to your doctor about whether any of these options might work for you. For a full comparison, see our alternatives guide.

How to Find Amphetamine/Dextroamphetamine XR in Stock

Here are the most effective strategies for locating your medication:

1. Use Medfinder

Medfinder shows you which pharmacies near your location currently have Amphetamine/Dextroamphetamine XR available. It's the fastest way to find stock without making dozens of phone calls.

2. Check Independent Pharmacies

Independent pharmacies often have better access to controlled substance stock because they work with multiple distributors. They're also more likely to go the extra mile to help you source your medication.

3. Ask About Alternative Strengths

If your specific strength is unavailable, your doctor may be able to adjust your prescription to use a combination of available strengths that equal your usual dose.

4. Fill Early When Possible

Most states allow you to fill Schedule II prescriptions 1-2 days before your current supply runs out. Don't wait until you're completely out to start searching.

For more detailed tips, see our post on how to find Amphetamine/Dextroamphetamine XR in stock near you.

Final Thoughts

The Amphetamine/Dextroamphetamine XR shortage has been one of the longest and most impactful medication shortages in recent memory. While 2026 is showing signs of improvement — thanks to DEA quota increases and expanded manufacturing — patients still face real challenges. Stay informed, use tools like Medfinder, and maintain regular communication with your prescriber to ensure your treatment doesn't get disrupted.

For related information, check out our posts on side effects and drug interactions for Amphetamine/Dextroamphetamine XR.